Application | Comment | Organism |
---|---|---|
medicine | tuberculosis, TB, target of anti-tubercular agents | Mycobacterium tuberculosis |
Protein Variants | Comment | Organism |
---|---|---|
I16T | isoniazid resistant clinical mutant, in silico constructed | Mycobacterium tuberculosis |
I21V | isoniazid resistant clinical mutant, in silico constructed | Mycobacterium tuberculosis |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.056 | - |
NADH | wild type enoyl-ACP reductase | Mycobacterium tuberculosis | |
0.104 | - |
NADH | I21V mutant enoyl-ACP reductase | Mycobacterium tuberculosis | |
0.149 | - |
NADH | I16T mutantwild type enoyl-ACP reductase | Mycobacterium tuberculosis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
acyl-[acyl-carrier protein] + NAD+ | Mycobacterium tuberculosis | - |
trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
acyl-[acyl-carrier protein] + NAD+ | - |
Mycobacterium tuberculosis | trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+ | - |
? |
Synonyms | Comment | Organism |
---|---|---|
enoyl reductase | - |
Mycobacterium tuberculosis |
enoyl-ACP reductase | - |
Mycobacterium tuberculosis |
enoyl-[acyl-carrier-protein] reductase | - |
Mycobacterium tuberculosis |
InhA | - |
Mycobacterium tuberculosis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADH | - |
Mycobacterium tuberculosis |